Listed company AVG invests in Adaptix

Mar 23, 2022 | Uncategorized

Partners focussed on transforming point-of-care imaging

Avingtrans has completed a minority £2.5m investment in emerging medtech leader, Adaptix

Adaptix’s focus is on transforming radiology, by allowing low-cost, low-dose 3D portable imaging. It has developed a number of novel technologies and imaging approaches in relation to Digital Tomosynthesis (“DT”). At the core of Adaptix’s technology is the ‘Flat Panel X-ray Source’ (FPS) which consists of a monoblock containing an array of individually controlled X-ray emitters combined with a high-voltage power supply.

Avingtrans, through its majority owned-subsidiary Magnetica (“MNA”), intends to collaborate with Adaptix, to develop a disruptive business offering. This offering will bring together low-cost 3D imaging in the form of MNA’s Cryogen-free MRI and Adaptix’s DT, to allow fusing of the image data, giving enhanced low-cost diagnostic capability, initially for orthopaedic imaging. The target markets include some 28,000 US sites focused on minor injuries (urgent care) and private orthopaedic practices (private practices and ambulatory surgical centres).

The purpose of the collaboration is to create a broader offering to customers than is delivered by each business alone and ultimately to bring together low-cost 3D MRI, X-ray and potentially ultrasound, in a solution which can address a significant proportion of all medical and veterinary imaging procedures.

Steve McQuillan, CEO of Avingtrans, commented: “We are excited by the prospect of Magnetica working with the team at Adaptix, to our mutual benefit. As fellow travellers on parallel disruptive medical imaging paths, we believe that working together will deliver cost and market synergies for both businesses to enhance potential shareholder value, through better quality and flexible multi-modal imaging, enhancing the end customer experience.”

Mark Evans, CEO of Adaptix, said: “Our vision is to offer multi-modal 3D imaging to under-served medical markets in major economies focused on extremity imaging, which will be driven by a ‘Pay-per-Study’ business model. Our competitive advantage will be facilitated by: the low cost of the equipment, protected and enabled by proprietary technology; equipment that does not need high-cost rooms and installation; and portability that enables equipment to be cheaply redeployed and therefore, facilitates new service models. We believe that by working with Avingtrans and Magnetica, we will be able to deliver a unique proposition to the medical imaging market.”

Hannah Lawrence-Lelitte (Assoc. CIPD) spent 10 years working as a senior Administrator for the University of Oxford and in HR and training roles across industries including publishing, environmental management and motorsport.

Hannah’s background is in Organisational Pyschology and she has a BSc in Psychology from the University of Surrey.

Martin Stofanko has a PhD in Immunology and MSc in Applied Genetics from University of Birmingham. Following Postdoctoral work at University of Cambridge he moved into industry in Brazil developing genetic tests for their low budget public healthcare system.

He is experienced in defining, executing and writing up quality assurance and technical documentations for IVDs and up to class IIa sterile MDs in the UK, Brazil and Germany. He has lead validation, external testing and transfer to manufacturing activities within company and outsourced abroad. He has established and extended ISO 13485 QMS from D&D to manufacturing, sales and distribution.

John has 30+ Years industry experience with a comprehensive background within Global Roles in Semiconductor, Electronics and Medical Device Industries.

Areas of expertise include, Start Up Operations, Programme and Performance Management, New Product Introduction and Product Outsource/Transfer.

Conrad Dirckx has a BA in Computer Science and PhD in MRI Imaging from Cambridge University as well as a master’s degree from the Ecole Centrale Paris in real-time computing. He has worked for GE Healthcare in their workstation, vascular x-ray and MRI business units and prior to joining Adaptix, spent 11 years working for Siemens in their molecular imaging division leading development projects for cardiology, neurology and oncology software products.

He is an APMP certified project manager who helped to pioneer the transition to lean/agile software development within Siemens MI.

Andy graduated with an Engineering Masters and boxing Blue from Oxford University, then gained Chartered Engineer status as a project manager while working for the Ministry of Defence. On the MOD Fast Stream, Andy gained corporate and leadership experience in a variety of strategic roles as well as leading counter terrorism teams in Iraq. Andy was awarded the Iraq medal and formally commended for changing the Coalition Forces campaign strategy.

Andy then went into leadership consulting & coaching (clients now diplomats & in No.10) and also moved into the commercial sector founding a film & TV company, raising finance and building relationships with the major studios. While he got the companies up and running Andy secured acting roles in Coronation Street and Emmerdale to help pay the bills.

Steve Wells spent 12 years developing medical devices for Siemens Molecular Imaging before joining Adaptix.

He has a PhD in Neuroscience, MSc in Medical Physics and a Natural Sciences degree from Cambridge. Prior to Siemens he worked as a software engineer on various commercial science projects.

Dr Siân Phillips MB,BCh MRCP FRCR is an experienced Consultant Radiologist based in South Wales.
She gained her undergraduate and postgraduate medical training in Wales. She has held several leadership roles during her career, including Associate Dean and Head of School at Health Education
and Improvement Wales; chair of Medical Imaging Sub-Committee and Imaging Essential Services Group, advising Welsh Government; and Clinical Director. As part of her active involvement in teaching and training, she has been involved in developing undergraduate curricula, been an FRCR examiner at the Royal College of Radiologists (RCR), and was instrumental in establishing and developing the National Imaging Academy, Wales. As a Fellow of the Royal College of Radiologists, she plays an active role in RCR activity.
Siân has extensive experience with Digital Tomosynthesis imaging in the general clinical setting. Her service was the first clinical department in the UK, second in Europe to introduce this innovative
technology. Her experiences with digital tomosynthesis she has shared widely, presenting at international conferences worldwide. She has sat on the Medical Advisory Board of GE Healthcare and acted as Medical Advisor to Adaptix for several years.

Adrian Crockett, BAcc, FCMA is a chartered management accountant who previously held the CFO position at Ocean Harvest Technology PLC where he helped raise £6m via an IPO, Thruvision PLC where he managed significant revenue growth towards £10m and at Venture Life PLC, an AIM listed consumer healthcare company where he was involved in the M&A of a number of businesses, participated in equity capital raises of over £25m and a revolving debt facility of similar with major UK & US banks. Before this he held senior financial management roles at Abbott Diabetes Care Ltd, a division of the US Healthcare company, Abbott, GSK & Novartis.

Sarah Small BSc, ACA is a Chartered Accountant with over 20 years’ experience of leading financial functions, including C-level experience within an AIM listed company.

Sarah has worked across a various number of industry sectors including digital marketing, retail, entertainment, education and construction. Sarah has a mathematics degree from Warwick University.